F126 - Practice Gaps in Dermatology: Are We Doing What the Evidence Tells Us We Should? Tips for Your Practice
Monday, February 19; 9:00 AM - 11:00 AM
Following this course, the attendee should be able to:
- 1. Define an example of a dermatology practice gap relevant to your practice.
- 2. Identify ways to overcome dermatology practice gaps you experience.
- 3. Identify barriers that make overcoming your relevant practice gaps difficult.
Dermatologists strive to provide high quality care to patients. The difference between what is actually done in practice and what should be done in practice based on best available evidence is called a practice gap. Through this interactive session, dermatologists can assess anonymously what they do in practice compared with their peers, and listen to experts talk about some of the more common, pertinent, or important practice gaps encountered in medical, surgical and other aspects of dermatology practice.
This activity has been approved by the American Board of Dermatology (ABD) for up to 20 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.
- Davis, Dawn M.R., MD: Regeneron – I(NC);
- Epps, Roselyn E., MD: no financial relationships exist with commercial interests.
- Friedlander, Sheila Fallon, MD: Menlo Therapeutics – A(H); Pfizer Inc. – A(H);
- Hand, Jennifer L., MD: UpToDate, Inc – C(IP);
- Reichenberg, Jason S., MD: Allergan, Inc – A(H);
Monday, February 19
Dr. Friedlander / Tinea capitis
Dr. Epps / Medications in Dermatology
Dr. Reichenberg / Pruritus
Dr. Hand / Genetic Testing